Photoacoustic Imaging Market Size, Share & Trends Analysis Report By Product (Photoacoustic Tomography (PAT), Photoacoustic Microscopy (PAM)), By Type (Pre-clinical, Clinical), By Application, By Region, And Segment Forecasts, 2023 - 2030
Photoacoustic Imaging Market Growth & Trends
The global photoacoustic imaging market size is anticipated to reach USD 339.02 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 19.27% from 2023 to 2030. The increase in the prevalence of chronic diseases, growing application in research and development activities, and rapid advancements in healthcare technology are key contributors to the market growth.
The advancement in photoacoustic imaging (PAI) offers a unique combination of structural and functional information, making it valuable for early disease detection and monitoring in healthcare. PAI is non-invasive and uses non-ionizing radiation, making it safer than traditional imaging methods and appealing to patients and healthcare providers. These factors are propelling the growth of the market. For instance, in August 2023, TomoWave launched LOIS-3D three-dimensional quantitative optoacoustic tomography (qOAT). Using the most attractive aspects of light and sound, this innovative technology creates three-dimensional visualizations of tiny animal models of human diseases with unsurpassed detail and contrast.
Consumer awareness of preventative healthcare is growing, and PAI is becoming easier to use. In the near future, it is also anticipated that manufacturers will increase their promotional efforts for photoacoustic imaging systems, which will accelerate their utilization. In addition, minimally invasive procedures have a high chance of success. Therefore, for diagnosis and treatment, patients worldwide favor less invasive PAI propelling market expansion.
Photoacoustic Imaging Market Report Highlights
- Based on product, the photoacoustic tomography (PAT) segment dominated the market in 2022 with the largest revenue share of 63.22% due to its high resolution, multiscale imaging, and accurate diagnosis of various diseases
- Based on application, the oncology segment dominated the market in 2022 with the highest revenue share of 52.68%. This share is attributed to photoacoustic imaging offering real-time monitoring of tumor responses to therapies and helping oncologists assess the effectiveness of treatments like chemotherapy
- Based on type, the pre-clinical segment dominated the market in 2022 with the largest revenue share of 79.57% owing to the increasing research and developments and advancement in imaging technology
- North America dominated the overall regional market with the highest revenue share of 42.81% in 2022, owing to the existence of a large number of market competitors in the region and the growing prevalence of chronic diseases in the region
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Technology
- 1.1.2. Type
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for Primary Interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for Primary Interviews in Latin America
- 1.3.5.5. Data for Primary Interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Type outlook
- 2.2.3. Application outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Photoacoustic Imaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of cancer
- 3.2.1.2. Rise in research studies in the field of non-ionizing radiation
- 3.2.1.3. Increasing range of applications
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack of skilled professionals
- 3.2.2.2. High cost of photoacoustic imaging system
- 3.2.2.3. Limited bandwidth to capture tomographic data
- 3.2.2.4. Limitations set by ANSI laser safety regulations
- 3.2.3. Market Opportunity Analysis
- 3.3. Photoacoustic Imaging Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic Landscape
- 3.3.3. Covid-19 Impact Analysis
- Chapter 4. Photoacoustic Imaging Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Photoacoustic Tomography (PAT)
- 4.1.2. Photoacoustic Microscopy (PAM)
- 4.2. Product Market Share, 2018 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Surgical Refractor Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 4.5.1. Photoacoustic Tomography (PAT)
- 4.5.1.1. Photoacoustic tomography (PAT) Market Estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Photoacoustic Microscopy (PAM)
- 4.5.2.1. Photoacoustic microscopy (PAM) market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. Handheld Ultrasound Devices: Type Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Pre-Clinical
- 5.1.2. Clinical
- 5.2. Type Market Share, 2018 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Photoacoustic Imaging Market by Type Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Pre-Clinical
- 5.5.1.1. Pre-Clinical market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Clinical
- 5.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. Photoacoustic Imaging Market: Application Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Oncology
- 6.1.2. Cardiology
- 6.1.3. Angiology
- 6.1.4. Histology
- 6.1.5. Interventional radiology
- 6.2. Application Market Share, 2018 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Photoacoustic Imaging Market by Application Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 6.5.1. Oncology
- 6.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.2. Cardiology
- 6.5.2.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.3. Angiology
- 6.5.3.1. Angiology market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.4. Histology
- 6.5.4.1. Histology market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.5. Interventional radiology
- 6.5.5.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 7. Photoacoustic Imaging Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
- 7.6. North America
- 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. U.S.
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 7.6.3. Canada
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
- 7.7. Europe
- 7.7.1. UK
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive Scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement scenario
- 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
- 7.7.2. Germany
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
- 7.7.3. France
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. France market estimates and forecasts, 2018 - 2030
- 7.7.4. Italy
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
- 7.7.5. Spain
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement scenario
- 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
- 7.7.6. Denmark
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory framework
- 7.7.6.4. Reimbursement scenario
- 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 7.7.7. Sweden
- 7.7.7.1. Key country dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory framework
- 7.7.7.4. Reimbursement scenario
- 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 7.7.8. Norway
- 7.7.8.1. Key country dynamics
- 7.7.8.2. Competitive Scenario
- 7.7.8.3. Regulatory framework
- 7.7.8.4. Reimbursement scenario
- 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
- 7.8. Asia Pacific
- 7.8.1. Japan
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Competitive Scenario
- 7.8.1.3. Regulatory framework
- 7.8.1.4. Reimbursement scenario
- 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
- 7.8.2. India
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. India market estimates and forecasts, 2018 - 2030
- 7.8.3. China
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. China market estimates and forecasts, 2018 - 2030
- 7.8.4. South Korea
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 7.8.5. Australia
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
- 7.8.6. Thailand
- 7.8.6.1. Key country dynamics
- 7.8.6.2. Competitive Scenario
- 7.8.6.3. Regulatory framework
- 7.8.6.4. Reimbursement scenario
- 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 7.9. Latin America
- 7.9.1. Brazil
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Competitive Scenario
- 7.9.1.3. Regulatory framework
- 7.9.1.4. Reimbursement scenario
- 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 7.9.2. Mexico
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory framework
- 7.9.2.4. Reimbursement scenario
- 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 7.9.3. Argentina
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory framework
- 7.9.3.4. Reimbursement scenario
- 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
- 7.10. MEA
- 7.10.1. SSouth Africa
- 7.10.1.1. Key country dynamics
- 7.10.1.2. Competitive Scenario
- 7.10.1.3. Regulatory framework
- 7.10.1.4. Reimbursement scenario
- 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 7.10.2. SSaudi Arabia
- 7.10.2.1. Key country dynamics
- 7.10.2.2. Competitive Scenario
- 7.10.2.3. Regulatory framework
- 7.10.2.4. Reimbursement scenario
- 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 7.10.3. UUAE
- 7.10.3.1. Key country dynamics
- 7.10.3.2. Competitive Scenario
- 7.10.3.3. Regulatory framework
- 7.10.3.4. Reimbursement scenario
- 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
- 7.10.4. KKuwait
- 7.10.4.1. Key country dynamics
- 7.10.4.2. Competitive Scenario
- 7.10.4.3. Regulatory framework
- 7.10.4.4. Reimbursement scenario
- 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key Company Market Share Analysis, 2022
- 8.3.4. Advantest Corporation
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. TomoWave
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Kibero GmbH
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. FUJIFILM VisualSonics Inc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Seno Medical Instruments
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. iThera Medical GmbH
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Aspectus GmbH
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Vibronix Inc.
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook